48 results on '"Rana, Zaker"'
Search Results
2. Identification of a Predictive Genomic Biomarker for Prostate-directed Therapy in Synchronous Low-volume Metastatic Castration-sensitive Prostate Cancer
3. Conditional Risk and Predictive Factors Associated With Late Toxicity in Patients With Prostate Cancer Treated With External Beam Radiation Therapy Alone in the Randomized Trial RTOG 0126
4. Racial Analysis of Clinical and Biochemical Outcomes in Patients With Prostate Cancer Treated With Low-Dose-Rate Brachytherapy
5. WNT Pathway Mutations in Metachronous Oligometastatic Castration-Sensitive Prostate Cancer
6. Radiation Therapy: Brachytherapy
7. Proton Pencil Beam Scanning Facilitates the Safe Treatment of Extended Radiation Targets for Hodgkin Lymphoma: A Report from the Proton Collaborative Group Registry.
8. Biochemical Control and Toxicity Outcomes of Stereotactic Body Radiation Therapy Versus Low-Dose-Rate Brachytherapy in the Treatment of Low- and Intermediate-Risk Prostate Cancer
9. Impact of stereotactic body radiation therapy on geriatric assessment and management for older patients with head and neck cancer using G8
10. Conditional Risks of Biochemical Failure and Prostate Cancer–Specific Death in Patients Undergoing External Beam Radiotherapy
11. Outcomes of a Dose-Escalated Stereotactic Body Radiation Phase 1 Trial for Patients With Low- and Intermediate-Risk Prostate Cancer
12. Identification of a Predictive Genomic Biomarker for Prostate-directed Therapy in Synchronous Low-volume Metastatic Castration-sensitive Prostate Cancer
13. Phase I trial of dose-escalated stereotactic radiosurgery (SRS) boost for unfavorable locally advanced oropharyngeal cancer
14. Clinical and Genomic Differences Between Advanced Molecular Imaging-detected and Conventional Imaging-detected Metachronous Oligometastatic Castration-sensitive Prostate Cancer
15. Prognostic impact of circulating tumor cells in oligometastatic hormone-sensitive prostate cancer following metastasis-directed therapy.
16. Genomic determinants of patterns of failure in metachronous oligometastatic castration-sensitive prostate cancer.
17. Phase 2 randomized total eradication of metastatic lesions following definitive radiation to the prostate in de novo oligometastatic prostate cancer (TERPs) trial.
18. Burnout in Radiation Oncology Physician Workforce: The Effect of Mindfulness and Fulfillment
19. Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials
20. Genomic biomarkers to guide precision radiotherapy in prostate cancer
21. High-risk, recurrent and oligometastatic prostate cancer: recent developments on the role of radiation
22. Computed tomography-based flap brachytherapy for non-melanoma skin cancers of the face
23. CT/PET 68Ga-DOTATATE for Gamma Knife Radiosurgery Planning and Target Delineation in Patients with Meningioma
24. Phase I Trial of Dose-Escalated Stereotactic Radiosurgery (SRS) Boost for Unfavorable Locally Advanced Oropharyngeal Cancer
25. RADT-39. 68Ga- DOTATATE CT/PET FOR GAMMA KNIFE RADIOSURGERY PLANNING AND TARGET DELINEATION IN PATIENTS WITH MENINGIOMA
26. 13. MANAGEMENT OF BRAIN METASTASES FROM SMALL CELL LUNG CANCER USING SRS
27. Stereotactic body radiotherapy as primary treatment for elderly and medically inoperable patients with head and neck cancer
28. RTHP-03. FRAME-BASED AND MASKED STEREOTACTIC RADIOSURGERY: A PATIENT EXPERIENCE COMPARISON WITH THE GAMMA KNIFE ICON
29. Quality of Life Outcomes Following Organ-Sparing SBRT in Previously Irradiated Recurrent Head and Neck Cancer
30. RADI-09. DEFINING PROGRESSION IN PATIENTS TREATED WITH TEN OR MORE BRAIN METASTASES FOLLOWING STEREOTACTIC RADIOSURGERY
31. Major complications from radiotherapy following treatment for atypical meningiomas
32. Outcomes and Toxicity Following Salvage Low-Dose-Rate Brachytherapy for Recurrent Prostate Cancer after Radiation Therapy
33. Outcomes in the radiosurgical management of metastatic spine disease
34. Outcomes After Gamma Knife Radiosurgery for Intracranial Meningiomas
35. Genomic Determinants Associated with Modes of Progression and Patterns of Failure in Metachronous Oligometastatic Castration-sensitive Prostate Cancer
36. Prognostic Significance of Immune Cell Infiltration in Muscle-invasive Bladder Cancer Treated with Definitive Chemoradiation: A Secondary Analysis of RTOG 0524 and RTOG 0712
37. (P20) Decreased PSA Nadir as a Result of Dose-Escalated Stereotactic Body Radiation for Patients With Low- and Intermediate-Risk Prostate Cancer
38. (OA18) Outcomes of a Dose-Escalated Stereotactic Body Radiation Phase I/II Trial for Patients With Low- and Intermediate-Risk Prostate Cancer
39. Decreased PSA nadir as a result of dose-escalated stereotactic body radiation for patients with low- and intermediate-risk prostate cancer.
40. P16 - Outcomes After Gamma Knife Radiosurgery for Intracranial Meningiomas
41. Sexual, irritative, and voiding outcomes, following stereotactic body radiation therapy for prostate cancer
42. Comparative dosimetric findings using accelerated partial breast irradiation across five catheter subtypes
43. Strut-Based Vs. Balloon-Based Brachytherapy: Hotspots, Skin Doses, and Rib Doses
44. The impact of patient characteristics on voiding symptoms, irritative symptoms, and sexual function, following stereotactic body radiotherapy for prostate cancer.
45. The effect of MRI or PET fusion in radiotherapy treatment planning on the pathological complete response rate in rectal adenocarcinoma.
46. Improved Irritative Voiding Symptoms 3 Years after Stereotactic Body Radiation Therapy for Prostate Cancer
47. (P037) Treatment of Prognostically Favorable Peripheral Nerve Sheath Tumors: A Single-Institution Experience.
48. Outcomes in the radiosurgical management of metastatic spine disease.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.